| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0009-9236(96)90145-9 |
| P698 | PubMed publication ID | 8941022 |
| P50 | author | Anders Lindahl | Q37369838 |
| P2093 | author name string | Knutson L | |
| Lennernäs H | |||
| Sandström R | |||
| Ungell AL | |||
| Abrahamsson B | |||
| Knutson TW | |||
| P2860 | cites work | A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability | Q28293773 |
| Permeability of small nonelectrolytes through lipid bilayer membranes | Q28303833 | ||
| A receptor-mediated pathway for cholesterol homeostasis | Q29616158 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat | Q34346428 | ||
| The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man. | Q34403687 | ||
| Evidence for the absorption of bile acids in the proximal small intestine of normo- and hyperlipidaemic subjects | Q34471927 | ||
| By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? | Q36884264 | ||
| Physiological disposition of HMG-CoA-reductase inhibitors | Q38005635 | ||
| Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors | Q40695762 | ||
| Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation? | Q40964553 | ||
| Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects | Q43222775 | ||
| Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers | Q44719725 | ||
| Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption | Q47443778 | ||
| Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism | Q51030961 | ||
| Regional rectal perfusion: a new in vivo approach to study rectal drug absorption in man. | Q52349665 | ||
| Anomalous parameter estimates in the one-compartment model with first-order absorption | Q52390350 | ||
| A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry | Q52740032 | ||
| The lack of effect of induced net fluid absorption on the in vivo permeability of terbutaline in the human jejunum | Q71252169 | ||
| Paracellular intestinal transport of six-carbon sugars is negligible in the rat | Q71737218 | ||
| In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (±)-fluvastatin* | Q71809356 | ||
| Estimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol | Q72320787 | ||
| Binding of fluvastatin to blood cells and plasma proteins | Q72578249 | ||
| Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone | Q72609875 | ||
| Determination of fluvastatin enantiomers and the racemate in human blood plasma by liquid chromatography and fluorometric detection | Q73002722 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 493-503 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Jejunal permeability and hepatic extraction of fluvastatin in humans | |
| P478 | volume | 60 |
| Q88388194 | A Refined Developability Classification System |
| Q52222033 | A comparison between direct determination of in vivo dissolution and the deconvolution technique in humans |
| Q43878472 | Assessing the impact of child/adult differences in hepatic first-pass effect on the human kinetic adjustment factor for ingested toxicants |
| Q35553211 | Clinical Pharmacokinetics of Atorvastatin |
| Q34257901 | Clinical pharmacokinetics of fluvastatin |
| Q77162545 | Concentration- and Region-dependent Intestinal Permeability of Fluvastatin in the Rat |
| Q42924415 | Effect of sodium bicarbonate as a pharmaceutical formulation excipient on the interaction of fluvastatin with membrane phospholipids |
| Q38559763 | Examining the Use of a Mechanistic Model to Generate an In Vivo/In Vitro Correlation: Journey Through a Thought Process |
| Q28360140 | HMG-CoA reductase inhibitors and P-glycoprotein modulation |
| Q41741549 | Human Intestinal Permeability |
| Q41561820 | Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models |
| Q43832628 | Intestinal absorption and biodistribution of cosalane and its amino acid conjugates: novel anti-HIV agents |
| Q35153169 | Intestinal drug absorption and bioavailability: beyond involvement of single transport function |
| Q85854921 | Lamivudine permeability study: A comparison between PAMPA, ex vivo and in situ Single-Pass Intestinal Perfusion (SPIP) in rat jejunum |
| Q50754829 | Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the Rat |
| Q41478162 | Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences |
| Q74131049 | Rat jejunal permeability and metabolism of mu-selective tetrapeptides in gastrointestinal fluids from humans and rats |
| Q73584104 | Regional Intestinal Permeability in Rats of Compounds with Different Physicochemical Properties and Transport Mechanisms |
| Q78018835 | Surface activity and concentration dependent intestinal permeability in the rat |
| Q31046543 | The effect of amiloride on the in vivo effective permeability of amoxicillin in human jejunum: experience from a regional perfusion technique |
| Q35846680 | The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique |
| Q36053628 | The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans |
| Q43985265 | The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans |
Search more.